Regular Primary Care Plays a Significant Role in Secondary Prevention of Ischemic Heart Disease in a Western Australian Cohort

doi:10.1007/s11606-011-1665-1

J Gen Intern Med. 2011 October; 26(10): 1092–1097.

Published online 2011 February 24. doi: 10.1007/s11606-011-1665-1

PMCID: PMC3181311

Regular Primary Care Plays a Significant Role in Secondary Prevention of Ischemic Heart Disease in a Western Australian Cohort

Kristjana Einarsdóttir, PhD,¹ David B. Preen, PhD,¹ Jon D. Emery, DPhil, FRACGP,² and C. D’Arcy J. Holman, PhD, FAFPHM¹

¹Centre for Health Services Research, School of Population Health M431, The University of Western Australia, 35 Stirling Highway, Crawley, 6009 Perth, Australia

²School of Primary, Aboriginal & Rural Health Care, The University of Western Australia, 328 Stirling Highway, Claremont, 6010 Perth, Australia

Kristjana Einarsdóttir, Phone: +61-8-64881298, Fax: +61-8-64881188, Email: kristjana.einarsdottir/at/uwa.edu.au.

Contributor Information.

Corresponding author.

Received August 26, 2010; Revised December 22, 2010; Accepted February 7, 2011.

This article has been cited by other articles in PMC.

Abstract

Background

Secondary prevention for established ischaemic heart disease (IHD) involves medication therapy and a healthier lifestyle, but adherence is suboptimal. Simply having scheduled regular appointments with a primary care physician could confer a benefit for IHD patients possibly through increased motivation and awareness, but this has not previously been investigated in the literature.

Objective

To estimate the association between regular general practitioner (GP) visitation and rates of all-cause death, IHD death or repeat hospitalisation for IHD in older patients in Western Australia (WA).

Design

A retrospective cohort design.

Participants

Patients aged

≥

65 years (n

31,841) with a history of hospitalisation for IHD from 1992–2006 were ascertained through routine health data collected on the entire WA population and included in the analysis.

Main Measures

Frequency and regularity of GP visits was determined during a three-year exposure period at commencement of follow-up. A regularity score (range 0–1) measured the regularity of intervals between the GP visits and was divided into quartiles. Patients were then followed for a maximum of 11.5 years for outcome determination. Hazard ratios and 95% confidence intervals were calculated using Cox proportional hazards models.

Key Results

Compared with the least regular quartile, patients with greater GP visit regularity had significantly decreased risks of all-cause death (2^nd least, 2^nd most and most regular: HR

0.76, 0.71 and 0.71); and IHD death (2^nd least, 2^nd most and most regular: HR

0.70, 0.68 and 0.65). Patients in the 2^nd least regular quartile also appeared to experience decreased risk of any repeat IHD hospitalisation (HR

0.83, 95%CI 0.71–0.96) as well as emergency hospitalisation (HR

0.81, 95%CI 0.67–0.98), compared with the least regular quartile.

Conclusions

Some degree of regular GP visitation offers a small but significant protection against morbidity and mortality in older people with established IHD. The findings indicate the importance of scheduled, regular GP visits for the secondary prevention of IHD.

KEY WORDS: ischemic heart disease, hospitalisations, GP visits, record linkage, primary care

INTRODUCTION

Ischemic heart disease (IHD) is the leading cause of death in Australia¹ and worldwide², with ischaemic heart disease affecting 637,000 Australian residents and accounting for 23,570 deaths in 2005¹. The condition was also responsible for the majority of the national cardiovascular disease burden when assessed in 2003³. The prevalence of this condition increases markedly with age, exceeding 33% in those aged

≥

75 years⁴. Despite declining incidence and mortality rates from ischaemic heart disease over recent years in developed countries including Australia⁵^,⁶, the associated economic burden remains high⁷.

Treatments for established ischaemic heart disease include lifestyle modification (e.g., smoking cessation, increased physical activity, caloric restriction), pharmacotherapy (e.g., aspirin, beta-blockers, statins, ACE inhibitors, nitrates, anti-thrombin regime) and surgical revascularisation procedures⁸^,⁹. After discharging their patients from hospital in Australia, primary care physicians share ischaemic heart disease management with specialist cardiologists¹⁰. The treatments usually involve medication therapy, promoting changes to a healthier lifestyle and participation in a cardiac rehabilitation (CR) program⁹. These secondary prevention strategies have been shown to be critical to management of the underlying disease and prevention of recurrent hospital admission and death¹¹^–¹³. In spite of the evidence, existing literature indicates that adherence to secondary prevention strategies is suboptimal¹²^–¹⁴. In particular, only about 30% of eligible patients access CR programs in Australia and the United States (US)¹⁵^,¹⁶. Since older age is one of the reasons for poor compliance¹⁷^,¹⁸, finding optimal secondary prevention strategies in older people with ischaemic heart disease is important. An Irish intervention trial found that up to four primary care visits annually improved cardiovascular outcomes¹⁹. It, however, remains to be investigated whether simply having scheduled regular appointments with a primary care physician confers a secondary prevention benefit for ischaemic heart disease. Such appointments are a proxy for proactive, planned primary care; a main feature of The Chronic Care Model, which has been found to improve patient care and health outcomes²⁰.

We studied this important issue in Western Australia (WA) using linked, whole-population routine health/medical data. In Australia, primary medical care is delivered predominantly through general practice, where the Australian general practitioner (GP) is equivalent to a US family physician certified by the American Board of Family Medicine²¹. In this study, we used a visitation regularity score previously developed by our group²²^,²³ to assess the regularity of intervals between GP visits and investigated the effects of visiting a GP regularly on repeated hospital admission and death in older ischaemic heart disease patients.

METHODS

Study Population

The WA Department of Health routinely collects administrative health/medical data on the whole WA population, which includes one-tenth of the entire Australian population, or 2.3 million people²⁴. The data are linked through the WA Data Linkage System (WADLS) using computerised probabilistic matching based on full name and address, and other identifiers²⁵^,²⁶. WADLS evaluations have shown that the matching procedures are 99.89% accurate²⁵.

We identified the study cohort using linked data on individuals aged

≥

65 years from 1 January 1992 to 31 December 2006 from the Hospital Morbidity Data System (HMDS), Mortality Register, the Medicare Benefits Schedule (MBS) and the State Electoral Roll. The data included: i) all procedures performed during hospital stay; ii) one principal and 20 secondary diagnoses; iii) dates and types of admissions and separations of inpatients; iv) date and primary cause of death; and v) dates and types of services and procedures provided by GPs who qualified for government subsidy²⁷^,²⁸. Registration information from the WA Electoral Roll was used to ascertain outward migration of the study population since electoral registration is compulsory for all adult Australian citizens residing in the country.

We ascertained ischaemic heart disease patients using any of the 21 diagnosis fields in the HMDS using ICD-9 and ICD-9-CM (410, 411, 412, 413, 414) and ICD-10-AM²⁹ (I20, I21, I22, I23, I24, I25) classifications. The study cohort included all patients

≥

65 years who had at least one hospitalisation for ischaemic heart disease during 1992–2006 (n

70,035). After excluding 5182 patients who were not registered on the WA Electoral Roll at any time during the study period, we included 64,853 patients in the study.

The study was approved by the Human Research Ethics Committees of The University of Western Australia and the WA Department of Health.

Exposure and Outcome Ascertainment

The observation period for each individual began on the date of the patient’s first ischaemic heart disease hospitalisation. Each patient was then censored at the end date of Electoral Roll registration (for outward migration), date of death, date of repeat ischaemic heart disease hospitalisation, or 31 December 2006, whichever came first. We divided the observation period into an exposure period (first three years), a separate wash-out period (next six months) and follow-up (from end of wash-out period to censoring date).

The exposure period was designated to ascertain the GP visitation pattern for each patient across a three-year period. We identified the GP visits using 127 MBS service items for clinic attendance, out-of-surgery consultation and home visits provided by a registered GP²⁷^,²⁸. To assess how regular the intervals were between GP visits for each individual, we used a previously developed visitation regularity score²²^,²³ since entropy-related scores from other fields were unsuitable for our purpose³⁰. This score was calculated as 1/[1

Var(Φ_i)] where Φ_i was the time interval between the (i-1)^th and i^th GP visits. It ranged from 0 to 1 (with 1 representing perfect regularity between GP visits) and was divided into quartiles for all analyses. We then applied a six-month ‘wash-out’ period following the exposure period to minimise the likelihood of reverse causation (protopathic) bias³¹^,³², whereby the increased frequency of health services immediately prior to hospital admission or death can create a misleading association. During this period, no exposures or outcomes were ascertained. Person-time of follow-up began after the wash-out period with patients being followed for a maximum of 11.5 years for determination of all-cause death, ischaemic heart disease death or repeat hospitalisation.

Statistical Analyses

We estimated the effects of GP visit regularity on (a) all-cause mortality, (b) ischaemic heart disease mortality, or (c) second ischaemic heart disease hospitalisation using Cox proportional hazards models, where hazard ratios and 95% confidence intervals estimated the incidence rate ratios. All models were adjusted for gender; age at first hospitalisation; indigenous status; Charlson Index of co-morbidity³³; area-based socio-economic status and residential remoteness (obtained from the Australian Census conducted every five years (ref)); and the best fitting second order fractional polynomial of GP visit frequency (as measured by the total number of GP visits during the three-year exposure period) to account for the non-linearity of this variable (GP visit frequency

GP visit frequency*ln(GP visit frequency)). No basis to reject proportionality was found after assessing the proportional hazards assumption for each covariate in each model. We performed all analyses using the statistical software SAS version 9.1 (SAS Institute Inc., Cary, NC, USA).

RESULTS

Our original study sample of patients who had been hospitalised for ischaemic heart disease in WA during 1992–2006 included 64,853 people. After excluding those with a too short observation period, missing information on GP visits, or who died or were hospitalised before commencement of follow-up, we included 49% (n

31,841) of the original patient sample in the mortality analysis and 20% (n

13,102) in the repeat-ischaemic heart disease hospitalisation analysis (Table 1).

Table 1

Characteristics of the WA Ischaemic Heart Disease Patients

≥

65 Years 1992–2006

In Table 2, we show the characteristics of the 31,841 ischaemic heart disease patients by quartiles of GP visit regularity. Female patients, non-indigenous patients, and patients living in major cities were more likely to have higher regularity of GP visitation, whereas male patients, indigenous patients, and patients from very remote areas were more likely to be in the lower regularity groups. Deaths, emergency hospital admissions, the number of GP visits, number of repeat hospitalisations and length of hospital stay were highest in the most regular visit group.

Table 2

Characteristics of 31,841 Wa Ischaemic Heart Disease Patients

≥

65 Years 1992–2006 by Groups of GP Visit Regularity

We show the associations between GP visit regularity and all-cause death, ischaemic heart disease death and repeat ischaemic heart disease hospitalisation in Table 3. Compared with the least regular quartile, patients in the other three quartiles representing more regular GP visitation all had similarly decreased rates of all-cause death (HRs: 0.76, 0.71, and 0.71) and ischaemic heart disease death (HRs: 0.70, 0.68, and 0.65). Patients in the 2^nd least regular quartile also appeared to experience a lower rate of any repeat ischaemic heart disease hospitalisation (HR

0.83, 95%CI 0.71–0.96) as well as emergency hospitalisation (HR

0.81, 95%CI 0.67–0.98), compared with the least regular quartile.

Table 3

Association of GP Visit Regularity with the Likelihood of all-Cause Mortality, Ischaemic Heart Disease Mortality and Repeat Ischaemic Heart Disease Hospitalisation for 31,841 (Mortality Analysis) and 13,102 (Hospital Analysis) WA Ischaemic Heart Disease (more ...)

DISCUSSION

This study is the first to comprehensively evaluate the benefits of regular primary care for the secondary prevention of ischaemic heart disease in older patients at the population level. The results suggest that a relatively small increase in regularity between GP visits is required in order to protect against all-cause mortality, ischaemic heart disease mortality and repeat ischaemic heart disease emergency hospitalisations in patients aged over 65 years with a history of hospitalisation for ischaemic heart disease.

Using whole-population, routinely-collected, administrative medical/health data was a strength of this study as it minimised recall bias and loss-to-follow-up. We felt confident in using WA hospital data for patient ascertainment as the WA Department of Health conducts quality audits of the ICD coding of hospital morbidity from hospital charts on a regular basis and a validation study found the accuracy of heart failure coding from this data to be exceptionally high³⁴. Furthermore, all but a very small number of state-funded GPs in WA qualify for government subsidy support and it is thus unlikely that any of the patients in our study had GP visits that we missed.

Despite the number of strengths, a few limitations warrant attention. Firstly, reverse causation (protopathic) bias can occur in health services research when the increased frequency of the health care services immediately prior to a disease outcome creates a misleading association between the two factors³². We attempted to minimise this problem by implementing a six months wash-out period between the exposure and follow-up periods, where no exposure or outcomes were ascertained. A wash-out period of this length has been shown in similar research to adequately account for this type of bias³¹. Secondly, the severity of the initial ischaemic heart disease hospitalisation may affect the inclination of a patient to seek regular primary care once discharged from hospital. We explored adjusting all our analyses for proxy measurements of intial ischaemic heart disease severity such as: admission type at first ischaemic heart disease hospitalisation (emergency/non-emergency); concurrent acute myocardial infarction at first ischaemic heart disease hospitalisation; length of first ischaemic heart disease hospital stay; and revascularisation procedure at first ischaemic heart disease hospitalisation. None of these adjustments had any significant effect on the associations or risk estimates demonstrated in the study and we therefore excluded these variables from the Cox regression models. Thirdly, a large part of our participants died or were re-hospitalized prior to commencement of follow-up and could thus not be included in the analysis. This may have been a cause for a concern regarding the efficacy of regular GP visits. However, the people who were included in the analysis were more likely to have regular GP visits, indicating that regular GP visits point towards better health and longevity. Lastly, using this type of data did create some limitations with respect to information availability as we were unable to assess continuity of care. This was due to the fact that we did not have information on whether the patients saw the same GP at each visit.

Evidence exists indicating that hospitalisation for a number of chronic health conditions could be preventable with sufficient primary care³⁵. These conditions are known as Ambulatory Care Sensitive Conditions (ACSCs) and include, as an example, diabetes, respiratory diseases, various cardiovascular diagnoses, and convulsive disorders³⁶. The protective effect of GP accessibility and the pattern of GP contact against potentially preventable hospital admissions and adverse health events has been supported by several previous studies³⁵^,³⁷^–⁴¹. As an example, high primary care physician density appears to protect against potentially preventable hospital admissions³⁵, whereas lack of a primary care physician³⁸, fewer physician visits³⁹, living in primary medical care shortage areas⁴⁰, and lack of access to primary care⁴¹ appear to lead to increase in preventable hospitalisations. Also, delayed access to health care has been found to increase the risk of mortality in veterans⁴².

Our results support the findings from an Irish intervention study where ischaemic heart disease patients visited their primary care physician up to four times annually¹⁹. The authors reported improvements in blood pressure, cholesterol levels, and smoking status despite the fact that no special interventions on diet or physical activity were implemented for the patients¹⁹. Rather, GPs only provided advice/encouragement on healthy eating and physical exercise in addition to taking physical and medical measurements¹⁹. Hence, simply visiting a GP regularly appears to play a significant role in the prevention of deteriorating cardiovascular health. In our study, we used a new measure for regularity previously developed by our group²²^,²³ that specifically measured regularity between GP visits per se, and found that visiting a GP regularly appears to protect against morbidity and mortality in ischaemic heart disease patients. The results suggested that only relatively small increase in regularity is required in order to be protective and that when this threshold is reached, only a small additional benefit of increased regular GP attendance is apparent. The fact that regular primary care seems protective is an important finding considering that the literature consistently reports sub-optimal compliance with recommended secondary prevention strategies despite a plethora of evidence showing the importance of such strategies. For example, a recent systematic review concluded that pre-planned community pharmacist or nurse consultations, patient education and structured monitoring of medication and risk factors improved total cholesterol levels in patients with ischaemic heart disease¹¹. Also, clinical trial evidence consistently supports the efficacy of pharmacotherapies in reducing cardiovascular morbidity and mortality¹²^,¹³ and rehabilitation programs have been shown to play a pivotal role in treatment and management of ischaemic heart disease patients⁴³^–⁴⁵. As a result, clinical guidelines commonly suggest that all patients with ischaemic heart disease should participate in at least some form of a secondary prevention program⁴⁶.

Despite the ability of current preventive strategies to reduce cardiovascular morbidity and mortality, compliance remains poor¹²^–¹⁴. Some of the reasons for poor compliance include older age, lower socio-economic status, lack of motivation, transport difficulties, limited availability of preventive programs, and financial constraints¹⁷^,¹⁸. One feature of The Chronic Care Model²⁰—which focuses on proactive, planned care—includes automated reminder systems to support regular care. If put in place, such systems could make a great contribution towards increasing compliance rates. Furthermore, the vast majority of Australians over 65 years of age are eligible to receive a government concession card, entitling them to visit a GP regularly at low or no out-of-pocket expense. As a result, regular appointments with GPs are a financially feasible way for older patients to manage and monitor their disease, at least in the Australian setting.

Regular appointments with a GP as a form of secondary prevention for ischaemic heart disease reflect a more proactive approach to disease management. They create time to review the secondary prevention strategies in place, such as medication therapy, and may contribute towards medication adherence and early detection of adverse disease symptoms. In addition, regular GP appointments may help reduce stress and anxiety experienced by the patient. Evidence suggests that the reduction of emotional stress is an important consequence of secondary prevention⁴⁷. Hence, any psychosocial support provided by the GP is likely to contribute towards reduction in future coronary risk.

Another possible mechanism for the positive effect of regular primary care is the long-term maintenance of a healthy lifestyle. Patients with a recently diagnosed ischaemic heart disease tend to begin a new healthy lifestyle with good intentions. However, the maintenance of a healthy lifestyle depends on long-term advice and personal involvement in secondary prevention⁴⁸. As such, having regular appointments with a GP may increase the motivation of ischaemic heart disease patients to comply with secondary prevention strategies and stay on track with a healthy lifestyle. Such commitment will then in turn reduce their risk of mortality and morbidity in the long-term⁴⁹.

CONCLUSIONS

We investigated regular primary care as a possible secondary prevention strategy in older people who had been hospitalised for ischaemic heart disease in WA using linked, routine health data collected by the WA Department of Health. Our results indicated that visiting GPs at regular intervals protects against mortality and hospital admissions in older people with ischaemic heart disease. The findings point towards the importance of scheduled, regular GP visits for the secondary prevention of ischaemic heart disease.

ACKNOWLEDGEMENTS

We thank the following agencies for the data: the Australian Department of Health and Ageing, Medicare Australia, the Australian Electoral Commission, the Data Linkage Branch of the WA Department of Health, and the WA Registrar Generals Office. The research was funded by the Australia’s National Health and Medical Research Council. The results in this paper were presented at the 5^th Conference of Epidemiological Longitudinal Studies in Europe held in Paphos, Cyprus during 13–15 October 2010.

Conflict of Interest None disclosed.

Contributor Information

Kristjana Einarsdóttir, Phone: +61-8-64881298, Fax: +61-8-64881188, Email: kristjana.einarsdottir/at/uwa.edu.au.

David B. Preen, Phone: +61-8-64881307, Fax: +61-8-64881188, Email: david.preen/at/uwa.edu.au.

Jon D. Emery, Phone: +61-8-94495150, Fax: +61-8-93846238, Email: jon.emery/at/uwa.edu.au.

C. D’Arcy J. Holman, Phone: +61-8-64881251, Fax: +61-8-64881188, Email: darcy.holman/at/uwa.edu.au.

References

1. Australia’s health 2008. Australian Institute of Health and Welfare. Canberra: 2008. Cat. no. AUS 99.

2. Lopez AD, Mathers CD. Measuring the global burden of disease and epidemiological transitions: 2002–2030. Ann Trop Med Parasitol. 2006;100:481–499. doi: 10.1179/136485906X97417. [PubMed] [Cross Ref]

3. Begg S, Vos T, Barker B, Stevenson C, Stanley L, Lopez A. The burden of disease and injury in Australia 2003. Australian Institute of Health and Welfare. Canberra: 2007. AIHW cat. no. PHE 82.

4. Briffa T, Hickling S, Knuiman M, Hobbs M, Hung J, Sanfilippo FM, et al. Long term survival after evidence based treatment of acute myocardial infarction and revascularisation: follow-up of population based Perth MONICA cohort, 1984–2005. BMJ. 2009;338:b36. doi: 10.1136/bmj.b36. [PMC free article] [PubMed] [Cross Ref]

5. Beaglehole R, Stewart AW, Jackson R, Dobson AJ, McElduff P, D'Este K, et al. Declining rates of coronary heart disease in New Zealand and Australia, 1983–1993. Am J Epidemiol. 1997;145:707–713. doi: 10.1093/aje/145.8.707. [PubMed] [Cross Ref]

6. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet. 1999;353:1547–1557. doi: 10.1016/S0140-6736(99)04021-0. [PubMed] [Cross Ref]

7. Health care expenditure on cardiovascular diseases 2004–05. Australian Institute of Health and Welfare. Canberra: 2008. Cat. no. CVD 43.

8. Bhatheja R, Mukherjee D. Acute coronary syndromes: unstable angina/non-ST elevation myocardial infarction. Crit Care Clin. 2007;23:709–735. doi: 10.1016/j.ccc.2007.07.003. [PubMed] [Cross Ref]

9. Junnila JL, Runkle GP. Coronary artery disease screening, treatment, and follow-up. Prim Care. 2006;33:863–885. doi: 10.1016/j.pop.2006.09.011. [PubMed] [Cross Ref]

10. General practice activity in Australia 2008–09. General practice series no. 25. Australian Institute of Health and Welfare and the University of Sydney. 2009. AIHW cat. no. GEP 25.

11. Buckley BS, Byrne MC, Smith SM. Service organisation for the secondary prevention of ischaemic heart disease in primary care. Cochrane Database Syst Rev.3:CD006772. [PubMed]

12. Rockson SG. deGoma EM, Fonarow GC. Reinforcing a continuum of care: in-hospital initiation of long-term secondary prevention following acute coronary syndromes. Cardiovasc Drugs Ther. 2007;21:375–388. doi: 10.1007/s10557-007-6043-1. [PubMed] [Cross Ref]

13. Brassard A. Identification of patients at risk of ischemic events for long-term secondary prevention. J Am Acad Nurse Pract. 2009;21:677–689. doi: 10.1111/j.1745-7599.2009.00444.x. [PubMed] [Cross Ref]

14. Chew DP, Amerena J, Coverdale S, Rankin J, Astley C, Brieger D. Current management of acute coronary syndromes in Australia: observations from the acute coronary syndromes prospective audit. Intern Med J. 2007;37:741–748. [PubMed]

15. Secondary prevention and rehabilitation after coronary events or stroke: a review of monitoring issues. Australian Institute of Health and Welfare. Canberra: 2003. AIHW Cat. No. CVD 25.

16. Wenger NK. Current status of cardiac rehabilitation. J Am Coll Cardiol. 2008;51:1619–1631. doi: 10.1016/j.jacc.2008.01.030. [PubMed] [Cross Ref]

17. Witt BJ, Thomas RJ, Roger VL. Cardiac rehabilitation after myocardial infarction: a review to understand barriers to participation and potential solutions. Eura Medicophys. 2005;41:27–34. [PubMed]

18. Daly J, Sindone AP, Thompson DR, Hancock K, Chang E, Davidson P. Barriers to participation in and adherence to cardiac rehabilitation programs: a critical literature review. Prog Cardiovasc Nurs. 2002;17:8–17. doi: 10.1111/j.0889-7204.2002.00614.x. [PubMed] [Cross Ref]

19. Bennett K, Jennings S, Collins C, Boland M, Leahy J, Bedford D, et al. Heartwatch: a secondary prevention programme in primary care in Ireland. Eur J Cardiovasc Prev Rehabil. 2008;15:651–656. doi: 10.1097/HJR.0b013e3283090020. [PubMed] [Cross Ref]

20. Coleman K, Austin BT, Brach C, Wagner EH. Evidence on the Chronic Care Model in the new millennium. Health Aff (Millwood) 2009;28:75–85. doi: 10.1377/hlthaff.28.1.75. [PubMed] [Cross Ref]

21. Bazemore AW, Xierali IM, Petterson SM, Phillips RL, Jr., Rinaldo JC, Puffer JC, et al. American Board of Family Medicine (ABFM) maintenance of certification: variations in self-assessment modules uptake within the 2006 cohort. J Am Board Fam Med.23:49–58. [PubMed]

22. Einarsdottir K, Preen DB, Emery JD, Holman CD. Regular primary care decreases the likelihood of mortality in older people with epilepsy. Med Care. 2010;48:472–476. doi: 10.1097/MLR.0b013e3181d68994. [PubMed] [Cross Ref]

23. Einarsdottir K, Preen DB, Emery JD, Kelman C, Holman CD. Regular primary care lowers hospitalisation risk and mortality in seniors with chronic respiratory diseases. J Gen Intern Med. 2010;25:766–773. doi: 10.1007/s11606-010-1361-6. [PMC free article] [PubMed] [Cross Ref]

24. Australian Demographic Statistics. Australian Bureau of Statistics. Canberra: 2010. cat. no. 3101.0.

25. Holman CD, Bass AJ, Rouse IL, Hobbs MS. Population-based linkage of health records in Western Australia: development of a health services research linked database. Aust N Z J Public Health. 1999;23:453–459. doi: 10.1111/j.1467-842X.1999.tb01297.x. [PubMed] [Cross Ref]

26. Holman CD, Bass AJ, Rosman DL, Smith MB, Semmens JB, Glasson EJ, et al. A decade of data linkage in Western Australia: strategic design, applications and benefits of the WA data linkage system. Aust Health Rev. 2008;32:766–777. doi: 10.1071/AH080766. [PubMed] [Cross Ref]

27. Harris MG, Harris RD. The Australian health system: continuity and change. J Health Hum Serv Adm. 1998;20:442–467. [PubMed]

28. Asthma in Australia 2008. Australian centre for asthma monitoring and Australian Institute of Health and Welfare. Canberra: 2008. AIHW cat. no. ACM 14.

29. Roberts RF, Innes KC, Walker SM. Introducing ICD-10-AM in Australian hospitals. Med J Aust. 1998;169(Suppl):S32–S35. [PubMed]

30. Liu H, Wong L. Data mining tools for biological sequences. J Bioinform Comput Biol. 2003;1:139–167. doi: 10.1142/S0219720003000216. [PubMed] [Cross Ref]

31. Tamim H, Monfared AA, LeLorier J. Application of lag-time into exposure definitions to control for protopathic bias. Pharmacoepidemiol Drug Saf. 2007;16:250–258. doi: 10.1002/pds.1360. [PubMed] [Cross Ref]

32. Strom BL. Pharmacoepidemiology. 4. West Sussex, England: Wiley; 2005.

33. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383. doi: 10.1016/0021-9681(87)90171-8. [PubMed] [Cross Ref]

34. Teng TH, Finn J, Hung J, Geelhoed E, Hobbs M. A validation study: how effective is the Hospital Morbidity Data as a surveillance tool for heart failure in Western Australia? Aust N Z J Public Health. 2008;32:405–407. doi: 10.1111/j.1753-6405.2008.00269.x. [PubMed] [Cross Ref]

35. Basu J, Friedman B, Burstin H. Primary care, HMO enrollment, and hospitalization for ambulatory care sensitive conditions: a new approach. Med Care. 2002;40:1260–1269. doi: 10.1097/00005650-200212000-00013. [PubMed] [Cross Ref]

36. Caminal J, Starfield B, Sanchez E, Casanova C, Morales M. The role of primary care in preventing ambulatory care sensitive conditions. Eur J Public Health. 2004;14:246–251. doi: 10.1093/eurpub/14.3.246. [PubMed] [Cross Ref]

37. Tsai CL, Griswold SK, Clark S, Camargo CA., Jr Factors associated with frequency of emergency department visits for chronic obstructive pulmonary disease exacerbation. J Gen Intern Med. 2007;22:799–804. doi: 10.1007/s11606-007-0191-7. [PMC free article] [PubMed] [Cross Ref]

38. Shi L, Samuels ME, Pease M, Bailey WP, Corley EH. Patient characteristics associated with hospitalizations for ambulatory care sensitive conditions in South Carolina. S Med J. 1999;92:989–998. doi: 10.1097/00007611-199910000-00009. [PubMed] [Cross Ref]

39. Rizza P, Bianco A, Pavia M, Angelillo IF. Preventable hospitalization and access to primary health care in an area of Southern Italy. BMC Health Serv Res. 2007;7:134. doi: 10.1186/1472-6963-7-134. [PMC free article] [PubMed] [Cross Ref]

40. Parchman ML, Culler SD. Preventable hospitalizations in primary care shortage areas. An analysis of vulnerable Medicare beneficiaries. Arch Fam Med. 1999;8:487–491. doi: 10.1001/archfami.8.6.487. [PubMed] [Cross Ref]

41. Bindman AB, Grumbach K, Osmond D, Komaromy M, Vranizan K, Lurie N, et al. Preventable hospitalizations and access to health care. JAMA. 1995;274:305–311. doi: 10.1001/jama.274.4.305. [PubMed] [Cross Ref]

42. Prentice JC, Pizer SD. Delayed access to health care and mortality. Health Serv Res. 2007;42:644–662. doi: 10.1111/j.1475-6773.2006.00626.x. [PMC free article] [PubMed] [Cross Ref]

43. McAlister FA, Lawson FM, Teo KK, Armstrong PW. Randomised trials of secondary prevention programmes in coronary heart disease: systematic review. BMJ. 2001;323:957–962. doi: 10.1136/bmj.323.7319.957. [PMC free article] [PubMed] [Cross Ref]

44. Taylor RS, Brown A, Ebrahim S, Jolliffe J, Noorani H, Rees K, et al. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med. 2004;116:682–692. doi: 10.1016/j.amjmed.2004.01.009. [PubMed] [Cross Ref]

45. Clark AM, Hartling L, Vandermeer B, McAlister FA. Meta-analysis: secondary prevention programs for patients with coronary artery disease. Ann Intern Med. 2005;143:659–672. [PubMed]

46. Reducing risk in heart disease. Guidelines for preventing cardiovascular events in people with coronary heart disease. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand; 2007.

47. Ades PA. Cardiac rehabilitation and secondary prevention of coronary heart disease. N Engl J Med. 2001;345:892–902. doi: 10.1056/NEJMra001529. [PubMed] [Cross Ref]

48. Dale KS, Mann JI, McAuley KA, Williams SM, Farmer VL. Sustainability of lifestyle changes following an intensive lifestyle intervention in insulin resistant adults: Follow-up at 2-years. Asia Pac J Clin Nutr. 2009;18:114–120. [PubMed]

49. Hedback B, Perk J, Wodlin P. Long-term reduction of cardiac mortality after myocardial infarction: 10-year results of a comprehensive rehabilitation programme. Eur Heart J. 1993;14:831–835. doi: 10.1093/eurheartj/14.6.831. [PubMed] [Cross Ref]

Articles from Journal of General Internal Medicine are provided here courtesy of
Society of General Internal Medicine